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Abstract
One hundred and seventy-six biopsies of the gastric corpus and
antrum from 97 patients were processed using classical and
molecular methods in order to study the relationship between
the factor cagA of Helicobacter pylori, bacterial load and morbid-
ity. Bacterial load in patients with cagA was greater than in
patients without it, both in the antrum and corpus (p < 0.01).
There was a statistically significant association between cagA and
consumption of proton pump inhibitors (adjusted odds ratio
3.11). Haemorrhage of the upper digestive tract was more asso-
ciated with bacterial load than with the cagA gene (adjusted
odds ratio 2.34 and 1.12, respectively), but none of these associ-
ations yielded statistical significance.
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CagA bacterial virulence factor has been considered to be
involved in gastric pathology associated with H. pylori [1,2].
Our aim was to evaluate the association between the num-
ber of microorganisms in the patient’s mucosa (bacterial
load) and cagA, and to determine whether they are associ-
ated with a greater severity of the clinical condition.
One hundred and seventy-six biopsies of the gastric cor-
pus and antrum from 97 consecutive patients in whom there
was clinical suspicion of infection by H. pylori (n = 52 duode-
nal ulcer, n = 15 duodenitis, n = 24 gastric ulcer, n = 6 gas-
tritis), were processed using Gram stain, culture, rapid
urease test, anatomopathological study and DNA extraction.
The quantification of the microorganisms was carried out
by amplifying a fragment of the urease gene. This system has
an internal control, also designed in our laboratory [3]. In
order to correct for the effect of the size of the gastric
biopsy the number of human cells in the biopsy sample was
quantified by amplifying the human albumin gene. The detec-
tion of the cagA gene was carried out using a real-time PCR
system (RT-PCR) designed and validated in our laboratory
[4].
The PCR values obtained were classified into three groups
based on the tertiles of each distribution of the number of
H. pylori microorganisms present according to RT-PCR:
scarce (up to 13.0), moderate (13.0–422.5) and abundant
(>422.5). The reference group corresponded to the lowest
bacterial load category.
In order to estimate associations between the cagA gene
and associated clinical factors, adjusted ORs were estimated
in different multivariate models.
The cagA gene was detected in 103 biopsies (58.5%), cor-
responding to 55 patients (57.3%) (5). CagA-positive patients
were on average 7.6 years younger than cagA-negative
patients (p = 0.04) and smokers (p = 0.02). No significant
differences were found for age, sex or other clinical and life-
style characteristics analysed.
Bacterial load was much higher in patients with the viru-
lence cagA gene: median cagA-positive antrum 345.4 (inter-
quartile rank (IR) 1710.5); median cagA-negative antrum 58.4
(IR 297.8) p = 0.002; median cagA-positive corpus 446.6 (IR
5190.6); median cagA-negative corpus 26.1 (IR 191.8)
p < 0.001.
In both the antrum and corpus a strong statistically signifi-
cant association was found between cagA and the number of
microorganisms when the bacterial load was divided into
three ordinal categories (scarce, moderate and abundant),
with a very significant dose–response pattern: crude odds
ratio for the highest category (ORH) in the antrum 4.28 (95%
CI 1.5–12.7), p trend = 0.009; ORH corpus 12.5 (95% CI 3.0–
52.5), p trend < 0.001. These associations became more
marked after adjusting for age, sex, upper digestive tract haem-
orrhage and prior antibiotic treatment (see Table 1).
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Table 2 shows the associations between digestive tract
morbidity, cagA and bacterial load adjusted for each other.
CagA is more closely associated with the consumption of
proton pump inhibitors than is the bacterial load: adjusted
OR cagA 3.11 (95% CI 1.0–9.6); ORH bacterial load 2.34. In
relation to clinical presentation of upper digestive tract
haemorrhage, although none of them yielded statistical signif-
icance, association was higher for bacterial load (ORH 2.34,
95% CI 0.6–8.5) than for cagA (OR 1.12). However, con-
sumption of NSAIDs (OR 8.99) or male sex (OR 3.26) is
more closely associated with upper digestive tract haemor-
rhage than with cagA gene or bacterial load. In the case of a
history of complicated ulcer, male sex is the factor most
strongly associated (OR 7.20).
Our data show that the cagA gene is detected in younger
people and it is statistically associated at high bacterial loads
with a clear, significant dose–response (p trend) relationship
between H. pylori load and presence of cagA. These data sug-
gest that both parameters combine to produce clinically sig-
nificant lesions, as compared with colonization by strains of
low virulence that multiply very little in the gastric mucosa
and so do not cause significant damage [5]. These data are
corroborated by the great variability in bacterial load values
obtained. In some patients the number of microorganisms in
the gastric mucosa was very small and therefore it is unlikely
in these cases that the microorganism had an important
influence on the patient’s pathology [6,7].
Our results suggest that the cagA gene is a risk factor
independent of bacterial load in patients with a history of
consumption of proton pump inhibitors (OR 3.11). This
association could be explained by the fact that the viru-
lence gene cagA produces greater gastric symptomatology,
thus fomenting consumption of proton pump inhibitors. It
may also be the case that consumption of these drugs
decreases the bacterial load, thus weakening their associa-
tion with the latter and strengthening their association with
cagA.
On the other hand, it is striking that clinical presentation in
the form of upper digestive tract haemorrhage (our most
robust variable as an indicator of the greater severity) seems
to be more associated with bacterial load than with the cagA
gene. Studies such as that by Molnar et al. [8] would support
the results of our study, because they found a significantly
increased bacterial density in gastric erosions when compared
with the healthy part of the gastric mucosa. Nevertheless, nei-
ther association with bacterial load nor association with the
TABLE 2. Association between digestive tract morbidity and sex, age, consumption of non-steroid anti-inflammatory drugs
and cagA and bacterial load (number of H. pylori microorganisms) adjusted for each other
UDTHa PPI consumptiona History of complicated
ulcer
ORb (95% CI) OR (95% CI) OR (95% CI)
CagA positive 1.12 (0.4–3.4) 3.11 (1.0–9.6) 2.92 (0.5–18.9)
Moderate antrum H. pylori loadc (13.0–422.5) 1.07 (0.3–3.9) 1.11 (0.3–3.8) 1.56 (0.2–10.5)
Abundant antrum H. pylori loadc (422.5 through highest) 2.34 (0.6–8.5) 0.30 (0.1–1.1) 0.46 (0.1–3.5)
Sex (male vs. female) 3.26 (1.1–9.7) 1.93 (0.7–5.6) 7.20 (0.9–59.5)
Age (£50 years vs. >50 years) 1.16 (0.4–3.6) 0.97 (0.3–2.8) 1.65 (0.3–10.5)
Consumption of non-steroid anti-inflammatory drugs 8.99 (2.2–37.1) 0.80 (0.3–2.3) 0.27 (0.0–2.7)
aUDTH denotes clinical presentation of upper digestive tract haemorrhage. PPI consumption denotes consumption of protein pump inhibitors.
bOdds ratios (OR) and 95% confidence intervals (95% CI) adjusted for sex, age (£50 years, >50 years), consumption of NSAIDs in the 7 days prior to the endoscopy (yes/
no), CagA status and RT-PCR categorized quantification in the antrum as surrogate for bacterial load.
cThe reference category was antrum bacterial load scarce (up to 13.0 H. pylori microorganisms per cell).
TABLE 1. Association between Cag A and number of microorganisms in the antrum and corpus, respectively
N CagA negative N CagA positive Crude OR (95% CI) Crude p-trend Adjusted ORa (95% CI) Adjusted p-trend
Antrum bacterial load > 0
Scarce (up to 13.0) 18 15 1.00b 1.00
Moderate (13.0–422.5) 16 14 1.05 (0.4–2.8) .009 1.76 (0.5–5.7) 0.003
Abundant (422.5 through highest) 7 26 4.29 (1.5–12.7) 6.83 (2.0–23.8)
Corpus bacterial load > 0
Scarce (up to 46.3) 17 10 1.00 1.00
Moderate (46.3–781.2) 12 17 2.41 (0.8–7.1) <0.001 2.91 (0.8–10.6) <0.001
Abundant (781.2 through highest) 3 22 12.47 (3.0–52.5) 17.26 (3.6–82.0)
aOdds ratios (OR) and 95% confidence intervals (95% CI) adjusted for gender, age (£vs. >50 years), consumption of NSAIDs in the 7 days prior to the endoscopy (yes/no),
and clinical presentation of upper digestive tract haemorrhage (yes/no).
bScarce categories were taken as the reference category.
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cagA gene yielded statistical significance in our study, so this
finding deserves further investigations.
In our study, we found that certain clinical factors, such as
the consumption of non-steroid anti-inflammatory drugs or
male sex, are more strongly associated with upper digestive
tract haemorrhage or a history of complicated ulcer than are
markers associated with H. pylori., This confirms that the
process producing alterations in the gastric mucosa is a com-
plex phenomenon in which infectious and non-infectious phe-
nomena interact [9].
In conclusion, the clear dose–response pattern between
bacterial load and the cagA gene confirm the importance of
quantifying the number of microorganisms present in the gas-
tric mucosa [10–12]) by means of molecular techniques
when evaluating the clinical importance and severity of infec-
tion due to H. pylori [13]. This makes it possible to study the
effect of the bacterial load on the relationship between
digestive tract morbidiy and the cagA gene with greater pre-
cision, thus contributing to a better understanding of the
complex interaction between the microorganism and gastric
mucosa [14,15].
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